We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Extends Comment Deadline for Quality Metrics Guidance to Nov. 27
FDA Extends Comment Deadline for Quality Metrics Guidance to Nov. 27
The FDA appears to have anticipated one issue drugmakers raised at a Monday public meeting on its quality metrics draft guidance — extending the comment period on the document until Nov. 27.